{
    "2021-03-18": [
        [
            {
                "time": "",
                "original_text": "董事长上任不足3月被刑拘，昔日对手市值已超十倍，CRO领域“理工男”进入多事之秋？ 董监高成员异常事件",
                "features": {
                    "keywords": [
                        "董事长",
                        "刑拘",
                        "CRO领域",
                        "理工男",
                        "多事之秋",
                        "董监高成员异常"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "CRO",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药、爱尔眼科、长春高新等医药白马跌至年线，是机会吗？",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "爱尔眼科",
                        "长春高新",
                        "医药白马",
                        "跌至年线"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}